Clinical trial
An Exploratory, Open Label Pharmacokinetic - Pharmacodynamic Study to Compare Subcutaneous Versus Intravenous Administration of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
NCT00505089 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory, Open Label Pharmacokinetic - Pharmacodynamic Study to Compare Subcutaneous Versus Intravenous Administration of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
- Lead sponsor
- Novartis
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- August 31, 2007
- Completion date
- Not reported
- Enrollment
- 11 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis